Twitter | Search | |
AstraZeneca
We're a global, science-led biopharmaceutical company & our innovative medicines are used by millions of patients worldwide. We believe in what science can do.
5,923
Tweets
1,391
Following
149,126
Followers
Tweets
AstraZeneca 1h
. recently published a call to action for HCPs to address cardio-renal risks in patients with T2D earlier. Learn more: .
Reply Retweet Like
AstraZeneca 8h
This video was created to help patients learn more about the connection between and cardiovascular disease, a largely overlooked complication of diabetes.
Reply Retweet Like
AstraZeneca 18h
In a world, our vision is to rest assured that patients' health is viewed as a whole and commonalities between cardiovascular, renal and metabolic diseases are clearly seen, understood and addressed. Read more: .
Reply Retweet Like
AstraZeneca 20h
Cardiovascular risk prevention is an important part of the management of type-2 diabetes. Through our approach, we aim to help increase collaboration among specialists, aiming to help raise awareness of risk factors. Learn more: .
Reply Retweet Like
AstraZeneca 24h
Mark Mallon, EVP, GPPS, GMA & CA, shares our commitment to treatment innovation
Reply Retweet Like
AstraZeneca Nov 12
Elisabeth Bjork, VP of Global Medicines Development, CVRM, discusses the need to address risk in patients. Learn more:
Reply Retweet Like
AstraZeneca Nov 12
The symptoms of are easily overlooked – until the disease has reached an advanced stage. This , share these common signs and symptoms to help us support earlier diagnosis and treatment for patients.
Reply Retweet Like
AstraZeneca Nov 12
Vascular and cardiac regeneration research is entering a new era. Our Head of IMED CVRM, , discussed advances we’re making in this area using new modalities at the Scientific Sessions. Read more about our work here: .
Reply Retweet Like
AstraZeneca Nov 12
Thank you for sharing your perspectives on improving 21st century health systems. We look forward to continuing these conversations to support sustainable access to healthcare and new medicines.
Reply Retweet Like
AstraZeneca Nov 11
Primary care physicians and specialists are the first line of defense in enabling people with to protect themselves from risk and . Be on the lookout for more insights on these findings to come at :
Reply Retweet Like
AstraZeneca Nov 11
Gaps remain between guidelines and clinical practice for patients hospitalised with acute coronary syndrome in China. However, we are helping make progress with the Care for Cardiovascular Disease in China Programme and are pleased to share the progress at .
Reply Retweet Like
AstraZeneca Nov 11
Total global health expenditures for treating & associated complications has increased by 8% in just two years and is now estimated to be USD $1.31 trillion. We're committed to working with our partners to reduce costs through the development of innovative treatments.
Reply Retweet Like
AstraZeneca Nov 11
A new consensus statement on addressing cardio-renal risks in patients with T2D earlier has just been published. Learn more:
Reply Retweet Like
AstraZeneca Nov 11
Patients need to recognise the importance of taking earlier action with their . Visit our new resource for patients with T2D:
Reply Retweet Like
AstraZeneca Nov 11
We’re at to participate in discussions on the latest research in health economics and outcomes research. Attendees can join us for a symposium on indication-based pricing on Monday, November 12th at 7:30-8:30 in Room 112.
Reply Retweet Like
AstraZeneca Nov 10
If you are a US adult with type-2 diabetes, you are 1.8 times more likely to be hospitalised for a heart attack than those without. We are aware of the relationships and are pushing the boundaries of addressing these diseases together.
Reply Retweet Like
AstraZeneca Nov 10
CVD is a major cause of death in people with diabetes. This represents the largest proportion of diabetes-related healthcare expenditure with 1 in 4 inpatient costs a result of CVD. We’re committed to addressing CVD risks in patients with T2D to help reduce these costs.
Reply Retweet Like
AstraZeneca Nov 10
The financial burden of recurrent cardiovascular disease is far reaching. We are committed to help reduce the burden by helping HCPs to improve secondary prevention and patient outcomes. Read more about what we are striving to do: .
Reply Retweet Like
AstraZeneca Nov 10
Our is proud to support At My Best with , bringing together emotional well-being, physical activity, and healthy eating in young children. Learn more about the programme here and let’s : .
Reply Retweet Like
AstraZeneca retweeted
AHA Meetings Nov 9
The official hashtag is - not . Spread the word.
Reply Retweet Like